SCHEMBL114283

SCHEMBL114283

CSc1ccc(CCc2ccc(F)nc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 8/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
MAOA P21397 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HTR2A P28223 1/20 0.37
KCNH2 Q12809 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 1/20 0.36
CNR2 P34972 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL115662 0.86 SLC6A4 (0.40) SLC6A4CYP11B1CYP11B2MAOASLC6A2
SCHEMBL9158077 0.79 TAAR1 (0.43) CYP11B1CYP11B2HTR2AKCNH2NPC1
SCHEMBL9156125 0.79 SMN1; SMN2 (0.46) CYP11B1CYP11B2HTR2AKCNH2NPC1
SCHEMBL1713352 0.78
SCHEMBL16613185 0.77 PTPRZ1 (0.45)
SCHEMBL9154293 0.76 NFKB1 (0.51) SLC6A4SLC6A2SLC6A3HTR2ANPC1
SCHEMBL9154340 0.75 NPC1 (0.40) CYP11B1CYP11B2HTR2AKCNH2NPC1
SCHEMBL9156732 0.75 RAB9A (0.50) CYP11B1CYP11B2HTR2AKCNH2NPC1
SCHEMBL115480 0.75 CYP1A1 (0.49) HTR2AKCNH2NPC1RAB9AMEN1
SCHEMBL9154167 0.75 RAB9A (0.49) SLC6A4SLC6A2SLC6A3HTR2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424859-A1 INHIBITORS OF PI3 KINASE AND / OR MTOR Amgen, Inc (US) 2012-03-07 EP disclosed
WO-2010126895-A1 INHIBITORS OF PI3 KINASE AND / OR MTOR AMGEN INC. (US) 2010-11-04 WO disclosed